|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: AMERICAN BIOGENETIC SCIENCES INC, 10-Q, 2000-08-10 |
Next: DBS INDUSTRIES INC, SB-2/A, 2000-08-10 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SIX MONTH YEAR TO DATE SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM AMERICAN BIOGENETIC SCIENCES, INC. 2000 10-Q FOR THE SECOND
QUARTER ENDED JUNE 30, 2000.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 3,112,000
<SECURITIES> 0
<RECEIVABLES> 316,000
<ALLOWANCES> 0
<INVENTORY> 538,000
<CURRENT-ASSETS> 4,031,000
<PP&E> 2,318,000
<DEPRECIATION> 1,896,000
<TOTAL-ASSETS> 7,259,000
<CURRENT-LIABILITIES> 600,000
<BONDS> 0
0
0
<COMMON> 44,000
<OTHER-SE> 6,595,000
<TOTAL-LIABILITY-AND-EQUITY> 7,259,000
<SALES> 844,000
<TOTAL-REVENUES> 1,435,000
<CGS> 288,000
<TOTAL-COSTS> 288,000
<OTHER-EXPENSES> 589,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 12,000
<INCOME-PRETAX> (1,532,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,532,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,532,000)
<EPS-BASIC> (.09)
<EPS-DILUTED> (.09)
</TABLE>
|
|